TUESDAY, July 15, 2025 (HealthDay News) — Approved label populations for new drugs are broader than trial populations overall, according to a study published online July 8 in the Annals of Internal Medicine. Kerstin N. Vokinger, M.D., J.D., Ph.D., from the University of Zurich, and colleagues conducted a cross-sectional study to examine the differences in […]
The post Approved-Label Populations for New Drugs Broader Than Trial Populations first appeared on Physician’s Weekly.
